Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changes in glomerular hemodynamic parameters in hypertensive patients after treatment with lercanidipine
2004-002232-26Phase 4Active
- Sponsor
- Hospital Universitario 12 de Octubre
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lercanidipine in hypertension (HTN), sponsored by Hospital Universitario 12 de Octubre. Primary endpoint: Change in glomerular filtration parameters. Started Apr 2005; status: active.
02
Drugs
lercanidipine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2004-002232-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-002232-26.